Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7551–7600 of 18652
appointed John Szczepanski as Chief Financial Officer of the Company and its subsidiaries, effective as of January 2, 2024.
Michael Hand, who was appointed Interim Chief Financial Officer effective as of July 1, 2023, will resign from such position effective as of January 2, 2024
On November 28, 2023, the Board appointed Lawrence D. Firestone as Chairman of the Board of Directors (“ Board ”), expanding the Board to eight directors, and as the Company’s Chief Executive Officer
On November 27, 2023, Scott Tarriff, President and Chief Executive Officer of Eagle Pharmaceuticals, Inc. (the “Company”), resigned and retired from his positions with the Company as President, Chief Executive Officer, Principal Executive Officer and Director on the Company’s Board of Directors (the “Board”), effective immediately.
Michael Graves, Chairman of the Board, was appointed Interim Executive Chairman of the Board and Interim Principal Executive Officer, effective immediately, until such time as a new Chief Executive Officer commences employment or such other date determined by the Board or upon his earlier resignation.
On November 22, 2023, David Pross, the CEO of Mobile Global Esports, Inc. (the “Company”) informed the Company’s Board of Directors that he will retire as Chief Executive Officer and Secretary of the Company, effective January 31, 2024.
our current Chief Financial Officer, Joseph Hernon, has notified us that he intends to retire at the end of his current employment contract on June 30, 2024.
On November 28, 2023, Apyx Medical Corporation (the “Company”) announced that it had appointed Matthew Hill as its Chief Financial Officer, effective December 4, 2023 (the “Effective Date”).
Ms. Krezmer was appointed President and Chief Executive Officer of the Company and of Generations Bank.
will remain President of the Company and the Bank following the effective date of Mr. Hobbs’ appointments
appointed Charles Daniel Hobbs Executive Vice President and Chief Financial Officer of both the Company and the Bank, effective December 4, 2023
On November 21, 2023, Matthew Hill submitted his resignation, effective December 1, 2023, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the “ Company ”) in order to pursue other professional endeavors.
On November 28, 2023, the Company entered into an Executive Employment Agreement with Lars Boesgaard (the “ Employment Agreement ”), pursuant to which Mr. Boesgaard will assume the role of the Company’s Chief Financial Officer, effective as of December 4, 2023.
appointed Cameron Turtle, DPhil, as Chief Executive Officer of the Company, effective as of November 22, 2023.
On November 28, 2023, Forestar Group Inc. (“the Company”) announced the upcoming retirement of Daniel C. Bartok, President and Chief Executive Officer, effective January 1, 2024.
On November 27, 2023, the Board of Directors appointed Anthony W. Oxley, age 59, as President and Chief Executive Officer, effective January 1, 2024.
the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and the Funds
On November 27, 2023, Ms. Anna Paglia gave notice to the Invesco DB US Dollar Index Trust (the “Trust”) and each of its underlying series, Invesco DB US Dollar Index Bearish Fund and Invesco DB US Dollar Index Bullish Fund (collectively, the “Funds”), that she is resigning from all positions at Invesco Capital Management LLC (the “Managing Owner”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and the Funds and as a Member of the Board of Managers of the Managing Owner (the “Board”), effective November 28, 2023 (the “Effective Date”).
On November 27, 2023, (i) the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and the Funds, and (ii) Invesco Group Services Inc., the sole member of the Managing Owner, appointed Mr. Hartigan to serve as a Member of the Board, as of the Effective Date.
that she is resigning from all positions at Invesco Capital Management LLC (the “Managing Owner”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and the Funds and as a Member of the Board of Managers of the Managing Owner (the “Board”), effective November 28, 2023 (the “Effective Date”).
the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board, effective immediately after the close of business on the Effective Date.
Ms. Anna Paglia gave notice to the Invesco CurrencyShares ® Australian Dollar Trust (the “Trust”) that she is resigning from all positions at Invesco Specialized Products, LLC (the “Sponsor”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board of Managers of the Sponsor (the “Board”), effective upon the close of business on November 28, 2023 (the “Effective Date”).
the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board, effective immediately after the close of business on the Effective Date.
Ms. Anna Paglia gave notice to the Invesco CurrencyShares ® Canadian Dollar Trust (the “Trust”) that she is resigning from all positions at Invesco Specialized Products, LLC (the “Sponsor”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board of Managers of the Sponsor (the “Board”), effective upon the close of business on November 28, 2023 (the “Effective Date”).
On November 27, 2023, the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board, effective immediately after the close of business on the Effective Date.
On November 27, 2023, Ms. Anna Paglia gave notice to the Invesco CurrencyShares ® Euro Trust (the “Trust”) that she is resigning from all positions at Invesco Specialized Products, LLC (the “Sponsor”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board of Managers of the Sponsor (the “Board”), effective upon the close of business on November 28, 2023 (the “Effective Date”).
On November 27, 2023, the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board, effective immediately after the close of business on the Effective Date.
On November 27, 2023, Ms. Anna Paglia gave notice to the Invesco CurrencyShares ® British Pound Sterling Trust (the “Trust”) that she is resigning from all positions at Invesco Specialized Products, LLC (the “Sponsor”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board of Managers of the Sponsor (the “Board”), effective upon the close of business on November 28, 2023 (the “Effective Date”).
Ms. Anna Paglia gave notice to the Invesco CurrencyShares ® Swiss Franc Trust (the “Trust”) that she is resigning from all positions at Invesco Specialized Products, LLC (the “Sponsor”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board of Managers of the Sponsor (the “Board”), effective upon the close of business on November 28, 2023
the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board, effective immediately after the close of business on the Effective Date.
On November 27, 2023, Ms. Anna Paglia gave notice to the Invesco CurrencyShares ® Japanese Yen Trust (the “Trust”) that she is resigning from all positions at Invesco Specialized Products, LLC (the “Sponsor”) and its affiliates, including her positions as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board of Managers of the Sponsor (the “Board”), effective upon the close of business on November 28, 2023 (the “Effective Date”).
On November 27, 2023, the Board appointed Mr. Brian Hartigan to serve as Chief Executive Officer and Principal Executive Officer of the Trust and as a Member of the Board, effective immediately after the close of business on the Effective Date.
However, Mr. Ozcelik and the Company agreed on November 21, 2023 that he would not continue as the Company's CEO due to personal reasons.
William J. Anderson was chosen by the Company's board of directors to serve as the Company's interim CEO.
Also effective January 1, 2024, Karen L. Sedgwick, 57, was promoted by the Board to be the executive vice president and chief financial officer of Sempra.
Dominick Zarcone will retire as the Company’s President and Chief Executive Officer effective June 30, 2024.
Effective July 1, 2024, Mr. Jude will be appointed President and Chief Executive Officer of the Company.
Effective as of Mr. Rosenblum’s departure, Brett Asnas, the Company’s Chief Financial Officer, will assume the responsibility of the Company’s principal accounting officer and will directly supervise and manage the Company’s accounting team.
Effective as of Mr. Rosenblum’s departure, Brett Asnas, our Chief Financial Officer, will assume the responsibility of the Company and Safe’s principal accounting officer
On November 20, 2023, Rave Restaurant Group, Inc.’s Chief Financial Officer, Mr. Clinton D. Fendley, provided notice of his resignation, effective as of December 1, 2023.
Effective November 27, 2023, the Board of Nuvation Bio Inc. (the “Company”) appointed Moses Makunje as the Company’s Principal Accounting Officer and Principal Financial Officer.
Accordingly, effective as of the Effective Time, each of Christopher W. Walters, the Company’s President and Chief Executive Officer (and the Company’s principal executive officer), Marc Mehlman, the Company’s Chief Financial Officer and Treasurer (and the Company’s principal financial officer), Todd Mackay, the President of Avantax Wealth Management (and a named executive officer), and Stacy Murray, the Company’s Chief Accounting Officer (and the Company’s principal accounting officer) (collectively, the “ Existing Officers ”) ceased to be officers of the Company.
Accordingly, effective as of the Effective Time, each of Christopher W. Walters, the Company’s President and Chief Executive Officer (and the Company’s principal executive officer), Marc Mehlman, the Company’s Chief Financial Officer and Treasurer (and the Company’s principal financial officer), Todd Mackay, the President of Avantax Wealth Management (and a named executive officer), and Stacy Murray, the Company’s Chief Accounting Officer (and the Company’s principal accounting officer) (collectively, the “ Existing Officers ”) ceased to be officers of the Company.
Ron Vachris will serve as President until December 31, 2023, and as President and Chief Executive Officer starting January 1, 2024.
Craig Jelinek, who will serve as Chief Executive Officer until December 31, 2023
On November 17, 2023, James H. Herlocker, III retired as President and Chief Executive Officer and a Director of Texas Community Bancshares, Inc. (the “Company”).
On November 21, 2023, the Company appointed Jason Sobel as President and Chief Executive Officer and a Director of the Company.
the previously announced resignation of current Chief Financial Officer John Price on that same date.
the Company appointed Paul Webster to act as the Company’s interim Chief Financial Officer beginning November 17, 2023
Donald A. Merril, the Company’s Executive Vice President and Chief Financial Officer, was terminated without cause effective October 20, 2023
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.